Withdrawal from repeated administration of morphine alters histamine-induced anxiogenic effects produced by intra-ventral hippocampal microinjection

Journal of Psychopharmacology

Volumn 24, Issue 6, 2010, Pages 881-889

  Zarrindast, Mohammad Reza ^a,b,c   Khodarahmi, Parvin ^d,e   Rezayof, Ameneh ^f   Oryan, Shahrbano ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Anxiety; Clobenpropit; Histamine; Morphine; Plus maze test; Pyrilamine; Ranitidine; Rat(s)

Indexed keywords

CLOBENPROPIT; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; MEPYRAMINE; MORPHINE SULFATE; RANITIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; MAZE TEST; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; HIPPOCAMPUS; HISTAMINE; HISTAMINE ANTAGONISTS; IMIDAZOLES; MALE; MICROINJECTIONS; MORPHINE; MOTOR ACTIVITY; PYRILAMINE; RANITIDINE; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME; THIOUREA;

EID: 77952979160     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109106956     Document Type: Article

References (58)

1. Arrang JM, Garbarg M., Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832-837.
2. Aston-Jones G., Harris GC (2004) Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47: 167-179.
3. Bannerman DM, Grubb M., Deacon RM, Yee BK, Feldon J., Rawlins JN (2003) Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res 139: 197-213.
4. Bartoletti M., Ricci F., Gaiardi M. (2007) A GABA(B) agonist reverses the behavioral sensitization to morphine in rats. Psychopharmacology (Berlin) 192: 79-85.
5. Brake KE, Hough LB (1992) Morphine-induced increases of extracellular histamine levels in the periaqueductal grey in vivo: a microdialysis study. Brain Res 572: 146-153.
6. Brown RE, Stevens DR, Haas HL (2001) The physiology of brain histamine. Prog Neurobiol 63: 637-672.
7. Cadoni C., Di Chiara G. (1999) Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 90: 447-455.
8. Carlezon WA, Jr, Nestler EJ (2002) Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse ? Trends Neurosci 25: 610-615.
9. Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon WA, Jr (2006) Behavioral and molecular effects of Dopamine D1 Receptor stimulation during naloxone-precipitated morphine withdrawal. J Neurosci 26: 6450-6457.
10. Da Silva WC, Bonini JS, Bevilaqua LR, Izquierdo I., Cammarota M. (2006) Histamine enhances inhibitory avoidance memory consolidation through a H2 receptor-dependent mechanism. Neurobiol Learn Mem 86: 100-106.
11. Drutel G., Peitsaro N., Karlstedt K., et al. (2001) Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59: 1-8.
12. Eidi M., Zarrindast MR, Eidi A., Oryan S., Parivar K. (2003) Effects of histamine and cholinergic systems on memory retention of passive avoidance learning in rats. Eur J Pharmacol 465: 91-96.
13. El Kadi AO, Sharif SI (1996) The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice. Pharmacol Biochem Be 55: 49-54.
14. Ferrada C., Ferre S., Casado V., et al. (2008) Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55: 190-197.
15. Gogas KR, Hough LB, Eberle NB, et al. (1989) A role for histamine and H2-receptors in opioid antinociception. J Pharmacol Exp Ther 250: 476-484.
16. Good AJ, Westbrook RF (1995) Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats. Behav Neurosci 109: 631-641.
17. Haas H., Panula P. (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4: 121-130.
18. Henwood RW, Mazurkiewicz-Kwilecki IM (1977) Effect of histidine on morphine-induced changes in brain histamine. Agents Actions 7: 495-500.
19. Ito C. (2000) The role of brain histamine in acute and chronic stresses. Biomed Pharmacother 54: 263-267.
20. Khalilzadeh A., Zarrindast MR, Djahanguiri B. (2006) Effects of intracerebroventricular administration of ultra low doses of histaminergic drugs on morphine state-dependent memory of passive avoidance in mice. Behav Brain Res 166: 184-187. (Pubitemid 41677374)
21. Kuribara H. (1995) Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol 275: 251-258.
22. Li KW, Jimenez CR, Van der Schors RC, Hornshaw MP, Schoffelmeer AN, Smit AB (2006) Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 6: 2003-2008.
23. McCormick DA, Williamson A. (1991) Modulation of neuronal firing mode in cat and guinea pig LGNd by histamine: possible cellular mechanisms of histaminergic control of arousal. J Neurosci 11: 3188-3199.
24. Malmberg-Aiello P., Ipponi A., Bartolini A., Schunack W. (2002) Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacol Biochem Be 71: 313-318.
25. Munakata M., Akaike N. (1994) Regulation of K+ conductance by histamine H1 and H2 receptors in neurones dissociated from rat neostriatum. J Physiol 480: 233-245.
26. Nishibori M., Oishi R., Itoh Y., Saeki K. (1985) Morphine-induced changes in histamine dynamics in mouse brain. J Neurochem 45: 719-724. (Pubitemid 16238531)
27. Oishi R., Nishibori M., Itoh Y., Saeki K., Fukuda T., Araki Y. (1988) Histamine turnover in the brain of morphine-dependent mice. N- S Arch Pharmacol 337: 58-63. (Pubitemid 18061415)
28. Orofino AG, Ruarte MB, Alvarez EO (1999) Exploratory behaviour after intra-accumbens histamine and/or histamine antagonists injection in the rat. Behavioral Brain Research 102: 171-180.
29. Passani MB, Giannoni P., Bucherelli C., Baldi E., Blandina P. (2007) Histamine in the brain: beyond sleep and memory. Biochem Pharmacol 73: 1113-1122.
30. Paxinos G., Watson C. (1986) The rat brain in stereotaxic coordinates. Sydney: Academic Press.
31. Privou C., Knoche A., Hasenohrl RU, Huston JP (1998) The H1- and H2-histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology 37: 1019-1032.
32. Reiner PB, Kamondi A. (1994) Mechanisms of antihistamine-induced sedation in the human brain: H1 receptor activation reduces a background leakage potassium current. Neuroscience 59: 579-588.
33. Rodgers RJ, Johnson NJ (1995) Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Be 52: 297-303.
34. Rostami P., Hajizadeh-Moghadam A., Zarrindast MR (2006) The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours. Physiol Behav 87: 891-896.
35. Ruarte MB, Orofino AG, Alvarez EO (1997) Hippocampal histamine receptors and conflictive exploration in the rat: studies using the elevated asymmetric plus-maze. Braz J Med Biol Res 30: 1451-1461.
36. Sahraei H., Zarei F., Eidi A., et al. (2007) The role of nitric oxide within the nucleus accumbens on the acquisition and expression of morphine-induced place preference in morphine sensitized rats. Eur J Pharmacol 556: 99-106.
37. Snchez-Lemus E., Arias-Monta±o JA (2004) Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices. Neurosci Lett 364: 179-184.
38. Santos NR, Huston JP, Brandao ML (2003) Blockade of histamine H2 receptors of the periaqueductal gray and inferior colliculus induces fear-like behaviors. Pharmacol Biochem Be 75: 25-33.
39. Scheggi S., Masi F., Tagliamonte A., Gambarana C., Tolu P., De Montis MG (2000) Rats sensitized to morphine are resistant to the behavioral effects of an unavoidable stress. Brain Res 853: 290-298.
40. Schulteis G., Yackey M., Risbrough V., Koob GF (1998) Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharmacol Biochem Be 60: 727-731.
41. Selbach O., Brown RE, Haas HL (1997) Long-term increase of hippocampal excitability by histamine and cyclic AMP. Neuropharmacology 36: 1539-1148.
42. Shin IC, Kim HC, Swanson J., Hong JT, Oh KW (2003) Anxiolytic effects of acute morphine can be modulated by nitric oxide systems. Pharmacology 68: 183-189.
43. Shippenberg TS, Heidbreder C., Lefevour A. (1996) Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol 299: 33-39. (Pubitemid 26103434)
44. Suzuki T., Takamori K., Misawa M., Onodera K. (1995) Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Res 675: 195-202.
45. Wright IK, Upton N., Marsden CA (1992) Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berlin) 109: 338-346.
46. Yuzurihara M., Ikarashi Y., Ishige A., Sasaki H., Maruyama Y. (2000) Anxiolytic-like effect of saiboku-to, an oriental herbal medicine, on histaminergics-induced anxiety in mice. Pharmacol Biochem Be 67: 489-495.
47. Zarrindast MR, Babapoor-Farrokhran S., Babapoor-Farrokhran S., Rezayof A. (2008 b) Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci 82: 1175-1181.
48. Zarrindast MR, Ebrahimi-Ghiri M., Rostami P., Rezayof A. (2007 a) Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms. Behavioral Brain Research 181: 35-41.
49. Zarrindast MR, Farahmandfar M., Rostami P., Rezayof A. (2006 b) The influence of central administration of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice. J Psychopharmacol 20: 59-66.
50. Zarrindast MR, Farajzadeh Z., Rostami P., Rezayof A., Nourjah P. (2005 c) Involvement of the ventral tegmental area (VTA) in morphine-induced memory retention in morphine-sensitized rats. Behav Brain Res 163: 100-106.
51. Zarrindast MR, Hoghooghi V., Rezayof A. (2008 a) Inhibition of morphine-induced amnesia in morphine-sensitized mice: Involvement of dorsal hippocampal GABAergic receptors. Neuropharmacology 54: 569-576.
52. Zarrindast MR, Khalilzadeh A., Rezayat SM, Sahebgharani M., Djahanguiri B. (2005 d) Influence of intracerebroventricular administration of histaminergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Pharmacology 74: 106-112.
53. Zarrindast MR, Heidari-Darvishiani A., Rezayof A., Fathi-Azarbaijani F., Jafari-Sabet M., Hajizadeh-Moghaddam A. (2007 b) Morphine-induced sensitization in mice: changes in locomotor activity by prior scheduled exposure to GABAA receptor agents. Behav Pharmacol 18: 303-310.
54. Zarrindast MR, Moghadam AH, Rostami P., Roohbakhsh A. (2005 b) The effects of histaminergic agents in the central amygdala of rats in the elevated plus-maze test of anxiety. Behav Pharmacol 16: 643-649. (Pubitemid 41682199)
55. Zarrindast MR, Rostami P., Zarei M., Roohbakhsh A. (2005 a) Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats. Basic Clin Pharmacol 97: 276-281. (Pubitemid 41608119)
56. Zarrindast MR, Torabi M., Rostami P., Fazli-Tabaei S. (2006 a) The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Pharmacol Biochem Be 85: 500-506.
57. Zarrindast MR, Rezayof A. (2004) Morphine state-dependent learning: sensitization and interactions with dopamine receptors. Eur J Pharmacol 497: 197-204.
58. Zhang Z., Schulteis G. (2008) Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze. Pharmacol Biochem Be 89: 392-403.